Compare Bills

Primary Sponsor

Last Action

Ref To Com On Rules, Calendar, and Operations of the House2025-03-31

Vote Breakdown

No floor votes recorded.

Plain Language Summary

This bill revises North Carolina law regarding abortion-inducing drugs sent by mail or through remote means. It allows such drugs to be provided if a physician conducts an in-person informed consent meeting at least 72 hours beforehand, the drugs are FDA-approved, and standard informed consent requirements are met. The bill also establishes civil liability and enforcement mechanisms, including private lawsuits and potential criminal penalties.

Arguments in Favor

• •Supporters argue this bill protects women's health and safety by requiring in-person physician oversight before abortion-inducing drugs are provided remotely, ensuring women understand the procedure and potential risks.
• •Proponents contend that establishing medical standards and accountability for drug suppliers protects vulnerable women and allows the state to enforce safety requirements through civil and criminal penalties.

Arguments Against

• •Opponents argue this bill effectively restricts access to abortion-inducing drugs by requiring in-person physician consultations, which may be impractical for women in rural areas or with limited resources.
• •Critics contend the private right of action allowing lawsuits against patients, providers, and suppliers could chill lawful medical care and that the bill infringes on reproductive rights and medical autonomy.